Spero Appoints Thomas Parr, Ph.D. As Chief Scientific Officer
5/20/2014 6:58:53 AM
Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies targeting virulence and persistence, for treatment of bacterial infections, today announced that Thomas “Tom” Parr, Ph.D. has joined the company as Chief Scientific Officer. Dr. Parr is a highly regarded microbiologist with more than 25 years of drug discovery experience across both large pharmaceutical and small biotechnology companies. The company also announced its Scientific Advisory Board (SAB).
Help employers find you! Check out all the jobs and post your resume.
comments powered by